| Q47313479 | 1,25-dihydroxyvitamin D exerts similar immunosuppressive effects as UVR but is dispensable for local UVR-induced immunosuppression. |
| Q36512270 | A new view on cutaneous dendritic cell subsets in experimental leishmaniasis |
| Q34055422 | A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches |
| Q37320029 | A two-step model for Langerhans cell migration to skin-draining LN. |
| Q34988945 | A unique dermal dendritic cell subset that skews the immune response toward Th2 |
| Q92831475 | A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury |
| Q41906344 | Acute ablation of Langerhans cells enhances skin immune responses |
| Q44532074 | Advantages and limitations of mouse models to deplete dendritic cells |
| Q34749056 | Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. |
| Q42150655 | Alveolar epithelial cells orchestrate DC function in murine viral pneumonia |
| Q35797441 | Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis |
| Q82795328 | Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β |
| Q40162472 | Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice |
| Q34797596 | Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis |
| Q37048084 | Autoinflammatory Skin Disorders: The Inflammasomme in Focus |
| Q36294401 | Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state |
| Q42680098 | CD103+ Kidney Dendritic Cells Protect against Crescentic GN by Maintaining IL-10-Producing Regulatory T Cells |
| Q50964324 | CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells. |
| Q38572125 | CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis |
| Q30480094 | CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells |
| Q30513354 | Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo |
| Q47944296 | Cbfβ2 deficiency preserves Langerhans cell precursors by lack of selective TGFβ receptor signaling. |
| Q89000356 | Cell-intrinsic regulation of murine epidermal Langerhans cells by protein S |
| Q26829669 | Changing views of the role of Langerhans cells |
| Q37349759 | Characteristics and functions of murine cutaneous dendritic cells: a synopsis of recent developments |
| Q38569504 | Chemical allergy: translating biology into hazard characterization |
| Q34089167 | Classical Flt3L-dependent dendritic cells control immunity to protein vaccine |
| Q36742276 | Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells |
| Q34573130 | Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. |
| Q33927128 | Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming |
| Q34767725 | Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors |
| Q43647446 | Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells |
| Q90345190 | Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery |
| Q41160055 | Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis |
| Q38026993 | Cutaneous dendritic cells in allergic inflammation |
| Q37038461 | Cutaneous perspectives on adaptive immunity |
| Q42426613 | Cytip regulates dendritic-cell function in contact hypersensitivity. |
| Q37076474 | DNA damage, apoptosis and langerhans cells--Activators of UV-induced immune tolerance |
| Q37139265 | Demystifying the development of dendritic cell subtypes, a little |
| Q34982085 | Dendritic cell control of tolerogenic responses |
| Q37633373 | Dendritic cell subsets in primary and secondary T cell responses at body surfaces |
| Q37045247 | Dendritic cells and T cells in the regulation of cutaneous immunity |
| Q37038464 | Dendritic cells and contact dermatitis |
| Q38043960 | Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance |
| Q38117138 | Dendritic cells in the periphery control antigen-specific natural and induced regulatory T cells |
| Q39000247 | Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo |
| Q36690927 | Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response |
| Q50725780 | Development of intravital intermittent confocal imaging system for studying Langerhans cell turnover. |
| Q37349749 | Differentiation and heterogeneity in the mononuclear phagocyte system |
| Q37709827 | Disentangling the complexity of the skin dendritic cell network. |
| Q50099586 | Dissecting antigen processing and presentation routes in dermal vaccination strategies. |
| Q44862540 | Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation |
| Q37142696 | Dose metrics in the acquisition of skin sensitization: thresholds and importance of dose per unit area |
| Q39808301 | Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation |
| Q38719738 | Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance |
| Q36627450 | Early immune events in the induction of allergic contact dermatitis |
| Q37617470 | Effector and regulatory mechanisms in allergic contact dermatitis. |
| Q42867423 | Elevated Epidermal Ornithine Decarboxylase Activity Suppresses Contact Hypersensitivity |
| Q38991858 | Emerging Skin T-Cell Functions in Response to Environmental Insults |
| Q42407442 | EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen |
| Q52728576 | Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells. |
| Q34063859 | Epidermal Langerhans cells are not required for UV-induced immunosuppression |
| Q35913763 | Epidermal Langerhans cells tune skin reactivity to contact allergens |
| Q38071421 | Experimental models to investigate the function of dendritic cell subsets: challenges and implications |
| Q42053090 | Flk2+ myeloid progenitors are the main source of Langerhans cells |
| Q27317316 | Foxp3+ regulatory T cells are required for recovery from severe sepsis |
| Q26777948 | Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses |
| Q34306188 | Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity |
| Q43120646 | Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells |
| Q54341612 | Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. |
| Q38985483 | Functions of Murine Dendritic Cells |
| Q38129298 | Functions of the aryl hydrocarbon receptor in the skin |
| Q99248728 | Genetic models of human and mouse dendritic cell development and function |
| Q36258039 | Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. |
| Q36351364 | Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice |
| Q41813956 | Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy |
| Q37615661 | IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia |
| Q90244284 | IL1α antagonizes IL1β and promotes adaptive immune rejection of malignant tumors |
| Q34848159 | ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. |
| Q36294429 | Identification of a novel population of Langerin+ dendritic cells |
| Q36228168 | Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. |
| Q38449694 | Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes |
| Q35647916 | Immune Reactions against Gene Gun Vaccines Are Differentially Modulated by Distinct Dendritic Cell Subsets in the Skin |
| Q42854350 | Immune regulation by apoptotic cell clearance |
| Q37965921 | Immunological mechanisms of contact hypersensitivity in mice |
| Q39414548 | Immunological, chemical and clinical aspects of exposure to mixtures of contact allergens |
| Q37805075 | In vivo function of Langerhans cells and dermal dendritic cells |
| Q84511066 | Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival |
| Q36751598 | Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector |
| Q37268972 | Insights into Langerhans cell function from Langerhans cell ablation models |
| Q84598236 | Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs |
| Q37290106 | Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice |
| Q37441857 | Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis |
| Q94569713 | Langerhans Cells From Mice at Birth Express Endocytic- and Pattern Recognition-Receptors, Migrate to Draining Lymph Nodes Ferrying Antigen and Activate Neonatal T Cells in vivo |
| Q36035917 | Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease |
| Q47200811 | Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-Specific Regulatory T Cells. |
| Q47109271 | Langerhans Cells-Programmed by the Epidermis. |
| Q49024330 | Langerhans Cells: Sensing the Environment in Health and Disease |
| Q33590503 | Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network |
| Q39678964 | Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. |
| Q81639773 | Langerhans cell dogma: another round of rejections |
| Q40277855 | Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis. |
| Q37700833 | Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. |
| Q34973788 | Langerhans cells are negative regulators of the anti-Leishmania response. |
| Q36889254 | Langerhans cells are not required for efficient skin graft rejection |
| Q39189704 | Langerhans cells are not required for epidermal Vgamma3 T cell homeostasis and function |
| Q34542158 | Langerhans cells are not required for graft-versus-host disease |
| Q37294531 | Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens |
| Q35518655 | Langerhans cells are precommitted to immune tolerance induction |
| Q38446765 | Langerhans cells are required for UVR-induced immunosuppression |
| Q28294423 | Langerhans cells arise from monocytes in vivo |
| Q34009436 | Langerhans cells as targets for immunotherapy against skin cancer. |
| Q35935681 | Langerhans cells down-regulate inflammation-driven alveolar bone loss. |
| Q35913679 | Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. |
| Q42135895 | Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin |
| Q34179869 | Langerhans cells serve as immunoregulatory cells by activating NKT cells. |
| Q42049743 | Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. |
| Q37721150 | Langerhans cells: critical regulators of skin immunity? |
| Q82568945 | Langerhans cells: daughters of monocytes |
| Q36967801 | Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. |
| Q36073220 | Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity |
| Q29617381 | Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters |
| Q36969195 | Lentivirus as a potent and mechanistically distinct vector for genetic immunization |
| Q51888897 | Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity. |
| Q37125748 | Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract |
| Q82446939 | Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens |
| Q38207877 | Lymphocyte-based model systems for allergy research: a historic overview |
| Q33445574 | MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo |
| Q37117563 | Monocyte-derived dendritic cells in innate and adaptive immunity |
| Q37518598 | Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation. |
| Q36228955 | Monocytes give rise to mucosal, but not splenic, conventional dendritic cells |
| Q37153667 | Mucosal Langerhans Cells Promote Differentiation of Th17 Cells in a Murine Model of Periodontitis but Are Not Required for Porphyromonas gingivalis-Driven Alveolar Bone Destruction |
| Q38247413 | Murine and Human Model Systems for the Study of Dendritic Cell Immunobiology |
| Q37117761 | Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions |
| Q38090202 | Natural killer cells: walking three paths down memory lane |
| Q40121671 | Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance |
| Q24600864 | Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice |
| Q28081241 | Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT) |
| Q38952629 | Of skin and bone: did Langerhans cells and osteoclasts evolve from a common ancestor? |
| Q50020359 | Ontogeny and function of murine epidermal Langerhans cells |
| Q37716600 | Ontogeny and homeostasis of Langerhans cells |
| Q42767669 | Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells |
| Q34887778 | Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells |
| Q33632038 | Ovarian dendritic cells act as a double-edged pro-ovulatory and anti-inflammatory sword |
| Q47412450 | Pathomechanisms of Contact Sensitization. |
| Q28591976 | Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells |
| Q55260254 | Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease. |
| Q53523773 | Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients. |
| Q37139269 | Probing in vivo dendritic cell functions by conditional cell ablation. |
| Q40123089 | Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. |
| Q36751606 | Professional antigen-presenting cells of the skin |
| Q34875973 | Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. |
| Q84874206 | Re-examining cutaneous immunity |
| Q35754095 | Real-time visualization of macromolecule uptake by epidermal Langerhans cells in living animals |
| Q84983007 | Recent advances in the roles of dendritic cells on contact dermatitis |
| Q49592625 | Redefining the Role of Langerhans Cells As Immune Regulators within the Skin |
| Q26866216 | Regulatory dendritic cells for immunotherapy in immunologic diseases |
| Q37871640 | Research in practice: Different dendritic cell types in skin with various functions - important implications for intradermal vaccines |
| Q37237339 | Resident and "inflammatory" dendritic cells in human skin |
| Q37704952 | Revisiting the tolerogenicity of epidermal Langerhans cells |
| Q38136193 | Role of Th17 cells in skin inflammation of allergic contact dermatitis |
| Q34417553 | Role of immune-regulatory cells in skin pathology |
| Q30479248 | Roles for IL-1 and TNFalpha in dynamic behavioral responses of Langerhans cells to topical hapten application |
| Q38305806 | Runx3 regulates dendritic epidermal T cell development |
| Q48224316 | Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation. |
| Q35698924 | Severe dermatitis with loss of epidermal Langerhans cells in human and mouse zinc deficiency |
| Q51001008 | Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. |
| Q53218766 | Skin response to a carcinogen involves the xenobiotic receptor pregnane X receptor. |
| Q34801021 | Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization |
| Q36580331 | Specialized role of migratory dendritic cells in peripheral tolerance induction |
| Q34474499 | Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype |
| Q53588024 | Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation. |
| Q34334277 | Stimulation of CD8+ T cells following diphtheria toxin-mediated antigen delivery into dendritic cells |
| Q30435893 | Strategies and challenges in eliciting immunity to melanoma |
| Q33970584 | Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. |
| Q37949247 | Studying the mononuclear phagocyte system in the molecular age. |
| Q39874323 | TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation |
| Q64086728 | TLR7 Controls VSV Replication in CD169 SCS Macrophages and Associated Viral Neuroinvasion |
| Q51981445 | Targeted cell-ablation in Xenopus embryos using the conditional, toxic viral protein M2(H37A). |
| Q39164401 | The Importance of Dendritic Cells in Maintaining Immune Tolerance. |
| Q39882251 | The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system? |
| Q38367109 | The aryl hydrocarbon receptor: a review of its role in the physiology and pathology of the integument and its relationship to the tryptophan metabolism |
| Q38024308 | The bloodline of CD8α(+) dendritic cells |
| Q37122580 | The contribution of Langerhans cells to cutaneous malignancy |
| Q24685142 | The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells |
| Q26823101 | The diverse roles of mononuclear phagocytes in prion disease pathogenesis |
| Q36627481 | The evolving function of Langerhans cells in adaptive skin immunity |
| Q34848338 | The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFβ1-mediated homeostasis of Langerhans cells |
| Q33591053 | The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen |
| Q38214043 | The origins and functions of dendritic cells and macrophages in the skin |
| Q36655180 | The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice |
| Q44517145 | Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells |
| Q39843994 | UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin. |
| Q43694612 | Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity |
| Q47381299 | Ultraviolet B-Induced Maturation of CD11b-Type Langerin- Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin |
| Q64905083 | Uncovering the Mysteries of Langerhans Cells, Inflammatory Dendritic Epidermal Cells, and Monocyte-Derived Langerhans Cell-Like Cells in the Epidermis. |
| Q42028648 | Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines |
| Q37825528 | Use of defined TLR ligands as adjuvants within human vaccines. |
| Q35101495 | Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells |
| Q36277209 | Vaginal epithelial dendritic cells renew from bone marrow precursors |
| Q35166862 | Wnt signaling influences the development of murine epidermal Langerhans cells |
| Q42837656 | α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin |